Balyasny Asset Management’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-1,069,013
| Closed | -$56.1M | – | 1635 |
|
|
2020
Q3 | $56.1M | Buy |
+1,069,013
| New | +$56.1M | 0.41% | 31 |
|
|
2020
Q2 | – | Sell |
-91,044
| Closed | -$2.48M | – | 1459 |
|
|
2020
Q1 | $2.48M | Buy |
91,044
+19,017
| +26% | +$517K | 0.03% | 489 |
|
|
2019
Q4 | $1.42M | Buy |
+72,027
| New | +$1.42M | 0.01% | 720 |
|
|
2019
Q2 | – | Sell |
-67,881
| Closed | -$986K | – | 1653 |
|
|
2019
Q1 | $986K | Sell |
67,881
-8,435
| -11% | -$123K | 0.01% | 923 |
|
|
2018
Q4 | $843K | Sell |
76,316
-382,671
| -83% | -$4.23M | 0.01% | 850 |
|
|
2018
Q3 | $12.1M | Buy |
458,987
+137,549
| +43% | +$3.62M | 0.05% | 366 |
|
|
2018
Q2 | $6.57M | Buy |
321,438
+197,938
| +160% | +$4.05M | 0.03% | 496 |
|
|
2018
Q1 | $2.24M | Buy |
+123,500
| New | +$2.24M | 0.01% | 794 |
|
|
2015
Q2 | – | Sell |
-121,790
| Closed | -$1.85M | – | 1163 |
|
|
2015
Q1 | $1.85M | Buy |
+121,790
| New | +$1.85M | 0.02% | 442 |
|
|
2013
Q4 | – | Sell |
-60,318
| Closed | -$868K | – | 562 |
|
|
2013
Q3 | $868K | Buy |
+60,318
| New | +$868K | 0.01% | 389 |
|